Jim Simons Atossa Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,812,251 shares of ATOS stock, worth $1.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,812,251

Previous 1,855,101 2.31%

Holding current value

$1.4 Million

Previous $1.24 Million 21.1%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$0.59 - $1.03 $25,281 - $44,135	-42,850 Reduced 2.31%	1,812,251 $1.5 Million
Q1 2025 May 14, 2025	BUY	$0.67 - $1.01 $199,304 - $300,443	297,469 Added 19.1%	1,855,101 $1.24 Million
Q4 2024 Feb 13, 2025	BUY	$0.94 - $1.62 $232,708 - $401,050	247,562 Added 18.9%	1,557,632 $1.46 Million
Q3 2024 Nov 13, 2024	SELL	$1.09 - $1.52 $262,515 - $366,076	-240,840 Reduced 15.53%	1,310,070 $1.99 Million
Q2 2024 Aug 09, 2024	BUY	$1.03 - $2.1 $169,476 - $345,534	164,540 Added 11.87%	1,550,910 $1.85 Million
Q1 2024 May 13, 2024	BUY	$0.8 - $1.89 $81,680 - $192,969	102,100 Added 7.95%	1,386,370 $2.5 Million
Q4 2023 Feb 13, 2024	BUY	$0.63 - $0.98 $26,397 - $41,062	41,900 Added 3.37%	1,284,270 $1.13 Million
Q3 2023 Nov 14, 2023	BUY	$0.74 - $1.35 $124,542 - $227,205	168,300 Added 15.67%	1,242,370 $915,000
Q2 2023 Aug 11, 2023	BUY	$0.6 - $1.28 $82,800 - $176,640	138,000 Added 14.74%	1,074,070 $1.35 Million
Q1 2023 May 12, 2023	BUY	$0.59 - $0.91 $53,867 - $83,083	91,300 Added 10.81%	936,070 $679,000
Q4 2022 Feb 13, 2023	SELL	$0.5 - $1.01 $125,470 - $253,449	-250,940 Reduced 22.9%	844,770 $446,000
Q3 2022 Nov 14, 2022	SELL	$0.82 - $1.14 $733,313 - $1.02 Million	-894,285 Reduced 44.94%	1,095,710 $913,000
Q2 2022 Aug 12, 2022	SELL	$0.85 - $1.28 $93,922 - $141,436	-110,497 Reduced 5.26%	1,989,995 $2.17 Million
Q1 2022 May 13, 2022	BUY	$1.11 - $1.74 $1.03 Million - $1.62 Million	930,152 Added 79.48%	2,100,492 $2.63 Million
Q4 2021 Feb 11, 2022	BUY	$1.6 - $3.27 $1.87 Million - $3.83 Million	1,170,340 New	1,170,340 $1.87 Million
Q2 2021 Aug 13, 2021	SELL	$1.52 - $8.62 $5.02 Million - $28.5 Million	-3,304,140 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$0.92 - $4.33 $2.59 Million - $12.2 Million	2,811,340 Added 570.48%	3,304,140 $6.97 Million
Q4 2020 Feb 10, 2021	BUY	$0.85 - $2.43 $355,572 - $1.02 Million	418,320 Added 561.65%	492,800 $468,000
Q3 2020 Nov 13, 2020	BUY	$1.98 - $4.35 $147,470 - $323,988	74,480 New	74,480 $180,000
Q1 2020 May 14, 2020	SELL	$0.79 - $1.62 $20,698 - $42,444	-26,200 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$1.25 - $1.87 $32,750 - $48,994	26,200 New	26,200 $41,000

Others Institutions Holding ATOS

# of Institutions

Shares Held

28.6M

Call Options Held

42.5K

Put Options Held

63.5K

View Full List

About ATOSSA THERAPEUTICS, INC.

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $97.5M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

More about ATOS

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account